Plaintiffs Push To Alter Class Motions In Flonase MDL

Law360, New York (March 6, 2009, 12:00 AM EST) -- Following a December ruling by the U.S. Court of Appeals for the Third Circuit that set a new standard for considering class certification motions, the parties in multidistrict antitrust litigation over nasal spray Flonase have agreed that the plaintiffs should be allowed to file amended motions for class certification.

In a motion filed Thursday in the U.S. District of Court for the Eastern District of Pennsylvania, the parties said they had agreed it would be more efficient if the plaintiffs are permitted to amend and refile...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.